Delivering Insulin a Focus of Numerous and Diverse Product Development Efforts

D

(Amherst, NH) – While many investors and market observers gave up on alternative insulin delivery after the collapse of the inhaled insulin market in 2008, more than a dozen innovative and focused companies have not. A significant number of programs focused on alternative insulin delivery technologies continue to move forward. In terms of the range of formulation strategies and delivery technologies, alternative insulin delivery products currently in the pipeline represent the most diverse population of drug candidates of any prescription drug. All of these development-stage products share the common goal of reaping commercial success by creating patient-friendly insulin delivery methods that address the preference and compliance issues associated with traditional injection delivery methods.

The market for insulin will grow significantly as the rate of increase in the number of patients diagnosed with both Type I and Type II diabetes grows worldwide. Over the next six years, injectable and infusible insulin will have to compete with emerging insulin delivery methods – methods that include pulmonary, intranasal, transdermal and oral insulin delivery. Each of these alternative delivery methods will be competing to take market share away from traditional insulin delivery products, which will come under escalating pressure as new delivery systems are approved and commercialized.

A new report examines the implications of alternative insulin delivery on the diabetes management sector. Delivering Insulin: the Current Market and the Next Generation contains analysis of development-stage insulin products, assessments of market, technology and demand factors, and profiles of formulation and delivery technology companies.

More information is available at www.greystoneassociates.org .

About Greystone

Greystone Associates is a medical technology consulting firm focused on the areas of medical market strategy, product commercialization, venture development, and market research. We assist medical and healthcare market participants in achieving their business objectives through the creation of detailed development strategies, product commercialization programs, and comprehensive market and technology research and analysis. Our market research publications are designed, researched and written to provide timely and insightful information and data on focused market segments, with the aim of providing market participants with the essential knowledge to refine and execute their marketing plans and financial targets.

Contact:

Mark Smith
Voice: 603-595-4340
Fax: 603-804-0466
www.greystoneassociates.org

Source: Greystone Associates

About the author

By Cepheid